Yan-juan Zhu - Concepedia

Author

Yan-juan Zhu

Guangzhou University of Chinese Medicine ORCID

Also Known As

Y Zhu, Y. Zhu, Y.-P. Zhu, Yan-Juan Zhu, Yan-juan Zhu, Yanjuan Zhu, Zhu,Yuanyuan

Publications

418

Citations

H-Index

Concepts

All Affiliations

Guangzhou University of Chinese Medicine Guangdong Provincial Hospital of Traditional Chinese Medicine Sun Yat-sen University

About

Yan-juan Zhu is an author at Guangzhou University of Chinese Medicine specializing in lung cancer, cell biology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	56
2	Cell Biology	2	2	56
3	Pathology	2	2	56
4	Engineering	1	1	24
5	Molecular Biology	1	1	24

Yan-juan Zhu

Publications

268

Citations

H-Index

Page 1

	Year	Citations
Long noncoding RNA FAM201A involves in radioresistance of non-small-cell lung cancer by enhancing EGFR expression via miR-370. Liu Am, Yan-juan Zhu, Huang Zw, PubMed	2019	43
Bone metastasis attenuates efficacy of immune checkpoint inhibitors and displays “cold” immune characteristics in Non-small cell lung cancer Yan-juan Zhu, Xuesong Chang, Rui Zhou, Lung Cancer	2022	39
Acupuncture for Quality of Life in Gastric Cancer Patients Undergoing Adjuvant Chemotherapy Yan-juan Zhu, Xiaoyu Wu, Wei Wang, Journal of Pain and Symptom Management	2021	38
Quantitative cell-free circulating EGFR mutation concentration is correlated with tumor burden in advanced NSCLC patients Yan-juan Zhu, Haibo Zhang, Yi‐Hong Liu, Lung Cancer Tumor HeterogeneityMedicineTumor BurdenPathologyAdvanced Nsclc Patients	2017	32
<i>Yin-Cold</i> or <i>Yang-Heat</i> Syndrome Type of Traditional Chinese Medicine Was Associated with the Epidermal Growth Factor Receptor Gene Status in Non‐Small Cell Lung Cancer Patients: Confirmation of a TCM Concept Yan-juan Zhu, Haibo Zhang, Lirong Liu, Evidence-based Complementary and Alternative Medicine	2017	28
Association of mutant EGFR L858R and exon 19 concentration in circulating cell-free DNA using droplet digital PCR with response to EGFR-TKIs in NSCLC Yan-juan Zhu, Haibo Zhang, Yihong Liu, Oncology Letters EngineeringDna AnalysisMolecular BiologyPathologyNucleic Acid Amplification Test	2017	24
Estimation of cell-free circulating <i>EGFR</i> mutation concentration predicts outcomes in NSCLC patients treated with EGFR-TKIs Yan-juan Zhu, Haibo Zhang, Yi‐Hong Liu, Oncotarget	2017	21
Xie-Bai-San increases NSCLC cells sensitivity to gefitinib by inhibiting Beclin-1 mediated autophagosome formation Changju Ma, Xin Zhang, Xiaomin Mo, Phytomedicine	2024	16
Specific Gene Co-variation Acts Better Than Number of Concomitant Altered Genes in Predicting EGFR-TKI Efficacy in Non–small-cell Lung Cancer Yan-juan Zhu, Xin Qu, Dandan Zhan, Clinical Lung Cancer	2020	15
BYL719 reverses gefitinib-resistance induced by PI3K/AKT activation in non-small cell lung cancer cells Yaya Yu, Zhenzhen Xiao, Chenjing Lei, BMC Cancer	2023	12

Page 1